Human Antibodies Derived From Immunized Xenomice

Details for Australian Patent Application No. 2012203221 (hide)

Owner Amgen Fremont Inc.

Inventors Kucherlapati, Raju; Brenner, Daniel G.; Capon, Daniel J.; Jakobovits, Aya; Klapholz, Sue

Agent Cullens

Pub. Number AU-A-2012203221

Parent 2008202860

Filing date 31 May 2012

Wipo publication date 21 June 2012

International Classifications

C07K 16/18 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C12N 5/16 Undifferentiated human, animal or plant cells, e.g. cell lines - Animal cells

C12N 5/22 Undifferentiated human, animal or plant cells, e.g. cell lines - Human cells

C12N 15/13 Mutation or genetic engineering - Immunoglobulins

Event Publications

14 June 2012 Complete Application Filed

21 June 2012 Application Open to Public Inspection

  Published as AU-A-2012203221

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012203222-Method and Regents for Detecting Bioactive Lipids

2012203220-A vehicle support arm assembly